Perceptive Advisors - C4 THERAPEUTICS INC ownership

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 116 filers reported holding C4 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of C4 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$6,720,000
+16.3%
766,2310.0%0.20%
+7.7%
Q2 2022$5,777,000
-88.6%
766,231
-63.2%
0.18%
-82.1%
Q1 2022$50,526,000
-64.5%
2,082,723
-52.9%
1.01%
-7.7%
Q4 2021$142,252,000
+41.0%
4,417,826
+95.6%
1.10%
-25.2%
Q3 2021$100,913,000
-41.0%
2,258,566
-50.0%
1.47%
+32.1%
Q2 2021$170,928,000
+46.3%
4,517,132
+43.0%
1.11%
-24.8%
Q1 2021$116,835,000
+11.7%
3,158,5660.0%1.48%
+31.5%
Q4 2020$104,643,0003,158,5661.12%
Other shareholders
C4 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,990,334$3,702,0213.36%
Lynx1 Capital Management LP 1,019,230$1,895,7681.25%
Soleus Capital Management, L.P. 2,692,020$5,007,1570.46%
TCG Crossover Management, LLC 1,276,574$2,374,4270.35%
Bain Capital Life Sciences Investors, LLC 1,642,210$3,054,5110.34%
Nextech Invest Ltd. 375,857$699,0940.21%
Nantahala Capital Management 1,000,000$1,860,0000.16%
WASATCH ADVISORS LP 6,247,141$11,619,6820.07%
ArrowMark Colorado Holdings LLC 2,376,806$4,420,8590.05%
XTX Topco Ltd 96,042$178,6380.03%
View complete list of C4 THERAPEUTICS INC shareholders